Clinical Pharmacology: Advances and Applications, Volume 3, Issue (2011)

Browse this journal

Clinical Pharmacology: Advances and Applications, Volume 3, Issue (2011)

See all volumes and issues
Vol 16, 2024 Vol 15, 2023 Vol 14, 2022 Vol 13, 2021 Vol 12, 2020 Vol 11, 2019 Vol 10, 2018 Vol 9, 2017 Vol 8, 2016 Vol 7, 2015 Vol 6, 2014 Vol 5, 2013 Vol 4, 2012 Volume 3, 2011 Vol 2, 2010 Vol 1, 2009
Download citations Download PDFs Download issue

Case Report

Case Report
A case of cephalothin-associated urolithiasis
Ivan WM Lim, Peter JO Stride & Robert L Horvath
Pages: 1-3
Published online: 15 Dec 2022
AbstractforA case of cephalothin-associated urolithiasis | Full Text | References | PDF (188.3 KB)
  • 51 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Case Report
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome
Maro Ohanian, Christian Cable & Kathleen Halka
Pages: 5-12
Published online: 24 May 2011
AbstractforEculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome | Full Text | References | PDF (476 KB)
  • 73 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
Chirag G Patel, Li Li, Suzette Girgis, David M Kornhauser, Ernest U Frevert & David W Boulton
Pages: 13-25
Published online: 22 Jun 2011
AbstractforTwo-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole | Full Text | References | PDF (316 KB)
  • 107 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Detemir as a once-daily basal insulin in type 2 diabetes
Scott E Nelson
Pages: 27-37
Published online: 18 Aug 2011
AbstractforDetemir as a once-daily basal insulin in type 2 diabetes | Full Text | References | PDF (187.8 KB)
  • 62 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Case Series

Case Report
Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
Mahmud Mahamid, Reuven Mader & Rifaat Safadi
Pages: 39-43
Published online: 04 Oct 2011
AbstractforHepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions | Full Text | References | PDF (1.1 MB)
  • 194 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Case Report

Case Report
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
Maro Ohanian, Christian Cable & Kathleen Halka
Pages: 45-50
Published online: 01 Nov 2011
AbstractforReduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report | Full Text | References | PDF (341.2 KB)
  • 57 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Drug-resistant tuberculosis: emerging treatment options
Meghna Adhvaryu & Bhasker Vakharia
Pages: 51-67
Published online: 15 Dec 2022
AbstractforDrug-resistant tuberculosis: emerging treatment options | Full Text | References | PDF (390.3 KB)
  • 193 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Explore articles